| (210) | Number of the EPO application | 16747111 |
| (220) | Filing date of the EPO application | 2016.02.02 |
| (80) | EPO patent specification publication (B) | EPB nr. 12/2022, 2022.03.23 |
| (110) | EPO patent number | 3253412 |
| (21) | Number of the application | e 2017 0329 |
| (71) | Name(s) of applicant(s), code of the country | ALS Therapy Development Institute, US; |
| (72) | Name(s) of inventor(s), code of the country | LINCECUM John M., US;
JIANG Bingbing, US;
PERRIN Steven N., US;
GILL Alan, US;
GILL Cynthia A., US;
VIEIRA Fernando G., US; |
| (73) | Name(s) of owner(s), code of the country | ALS Therapy Development Institute, US; |
| (54) | Title of the invention | ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEASES OR DISORDERS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); A61K 39/395 (2006.01.01); A61P 21/00 (2006.01.01); A61P 21/04 (2006.01.01); A61P 25/00 (2006.01.01); A61P 25/16 (2006.01.01); A61P 25/28 (2006.01.01); A61P 29/00 (2006.01.01); A61P 37/02 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.02.28 |
| (30) | Priority | 201562111261 P, 2015.02.03, US |
| (86) | International application | PCT/US2016/016165, 2016.02.02 |
| (87) | International publication | WO 2016/126702, 2016.08.11 |